Cargando…
Analysis of RAS gene mutations in adverse events during first induction chemotherapy in childhood acute lymphoblastic leukemia
BACKGROUND: The rat sarcoma virus (RAS) pathway controls cell proliferation, differentiation, and apoptosis, which have been implicated in the pathogenesis of various hematological malignancies. Prognostic importance of RAS gene mutation, relatively frequently in childhood acute lymphoblastic leukem...
Autores principales: | Chen, Tianping, Wei, Nan, Lv, Wenxiu, Qu, Lijun, Liu, Hongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926126/ https://www.ncbi.nlm.nih.gov/pubmed/36798932 http://dx.doi.org/10.21037/tp-22-683 |
Ejemplares similares
-
Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM
por: Matheson, Elizabeth C., et al.
Publicado: (2019) -
Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
por: Mejía-Aranguré, Eréndira, et al.
Publicado: (2022) -
Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023) -
Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia
por: Severgnini, Marco, et al.
Publicado: (2022) -
Encephalopathy and brain atrophy during induction chemotherapy in acute lymphoblastic leukemia
por: Li, Qiao‐Ru, et al.
Publicado: (2020)